The acquisition will strengthen Seppic’s expertise and know-how with the addition of EPI’s internal production tools, giving the firm control over the entire process of research, development, and industrialization, from the extraction of raw materials to the active ingredients.
Seppic (La Garenne Colombes, France) has acquired EPI France, strengthening its position in the nutricosmetic market. EPI France’s flagship ingredient, Ceramosides, clinically validated to support skin both orally and topically, has been distributed by Seppic for over ten years. The acquisition will strengthen Seppic’s expertise and know-how with the addition of EPI’s internal production tools, giving the firm control over the entire process of research, development, and industrialization, from the extraction of raw materials to the active ingredients.
“This acquisition opens up new growth opportunities for Seppic in the cosmetics and dietary supplements markets. We are very pleased to welcome EPI France teams to Seppic,” said Jean Baptiste Dellon, CEO of Seppic, in a press release. “Our long-standing relationship and the values of expertise, quality and customer care that we share with EPI France will allow us to quickly realize synergies for the development and marketing of new ingredients.”
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.